Ramon M. Salazar - Publications

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

Journal: JCO global oncology

Published: August 13, 2026

LARP1 integrates MYC and mTOR signaling to enable anabolic growth during tumor initiation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 12, 2026

Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.

Journal: Journal of clinical medicine

Published: May 11, 2026

European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Response to the letter to the editor entitled "The precision of a report on precision".

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 25, 2025

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

Journal: ESMO open

Published: September 25, 2025

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Journal: Molecular oncology

Published: September 19, 2025

Toward risk-adjusted CT schedules in first-line metastatic colorectal cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 09, 2025

Early Supportive Versus Standard Care in Phase I Cancer Trials: A Randomized Controlled Trial.

Journal: Journal of pain and symptom management

Published: August 11, 2025

Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract.

Journal: Journal of neuroendocrinology

Published: July 16, 2025

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.

Journal: ESMO open

Published: June 16, 2025

Multiomic random forest toxicity modeling of radiation esophagitis.

Journal: Physics and imaging in radiation oncology

Published: May 20, 2025